MYCN and neuroblastoma: The association of MEK and BET inhibitors has synergistic effects in the majority of NB cells, but, unfortunately, has little activity in vivo models, being active only in a non-MYCN-amplified, NRAS-mutated NB xenograft model, while no activity was found in MYCN-amplified models [170].